Leong Mar
Follow
Get notifications in MyBN when activity occurs.
Leong Mar
Dr Leong Mar has over 20 years of technical and commercial experience from research organisations, technology companies, and one of the world’s iconic science corporations.
Dr Mar was the commercialisation director for the Missions Program at CSIRO, and an investment committee member of Uniseed Investments. Prior to that, Dr Mar was with global science corporation DuPont for 10 years, serving in a number of roles including as manager of the Australia and New Zealand Technology Centre, leader of the corporate business growth and innovation teams, a member of the country leadership team, and led the development and commercialisation of technology solutions including multi-industry award winning solutions for the mining sector.
Dr Mar is a Visiting Fellow at the University of New South Wales, and an Honorary Senior Fellow at University of Melbourne.
Dr Mar was the commercialisation director for the Missions Program at CSIRO, and an investment committee member of Uniseed Investments. Prior to that, Dr Mar was with global science corporation DuPont for 10 years, serving in a number of roles including as manager of the Australia and New Zealand Technology Centre, leader of the corporate business growth and innovation teams, a member of the country leadership team, and led the development and commercialisation of technology solutions including multi-industry award winning solutions for the mining sector.
Dr Mar is a Visiting Fellow at the University of New South Wales, and an Honorary Senior Fellow at University of Melbourne.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 110th | Chrysos Corporation | 87% | |
| 260th | ImpediMed | 38% | -19% |
| 1065th | FinTech Chain | -23% | -11% |
| 1176th | Credit Intelligence | -31% | -16% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 648th |  | Chrysos Corporation | $26.8m |
| 756th | | FinTech Chain | $13.2m |
| 757th | | Credit Intelligence | $13.2m |
| 759th | | Netccentric | $13.1m |
| 760th | | ImpediMed | $13.0m |
1328 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Commercial Director, CSIRO | 19 Apr 2022 |
| NEW ROLE: Non-Executive Director, Chrysos Corporation | 19 Apr 2022 |
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Director, Commercial Initiatives | | 2021 - 2023 | |
| Non-Executive Director | | 2017 - 2022 | 648 |
| Commercial Director | | 2020 - 2021 | |
| Commercialisation Manager | | 2015 - 2020 |
